Therapeutic outcomes of non-grafted and platelet concentrations-grafted transcrestal maxillary sinus elevation (TSFE): a systematic review and meta-analysis

T Guo, K Gulati, Z Shen, P Han, Z Fan - Scientific Reports, 2020 - nature.com
To evaluate and compare the stability, quantity and quality of bone augmentation at
maxillary sinus elevation sites by non-grafted transcrestal sinus floor elevation (TSFE) and …

Development of In vitro dry eye models to study proliferative and anti-inflammatory effects of allogeneic serum eye drops

S Voß, T Behrmann, S Reichl - International Journal of Molecular …, 2023 - mdpi.com
This study aimed to develop valid in vitro models for preclinical evaluation of proliferative
and anti-inflammatory effects of human allogeneic serum eye drops for dry eye disease …

Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technology

E Anitua, M de la Fuente, F Muruzabal… - Experimental Eye …, 2021 - Elsevier
Purpose To develop and characterize a new type of plasma rich in growth factors (PRGF)
membrane for patients in which immune system is involved in the disease etiology. Methods …

Short-and long-term stability of plasma rich in growth factors eye drops

E Anitua, M de la Fuente, F Muruzábal… - Cornea, 2021 - journals.lww.com
Purpose: To analyze whether plasma rich in growth factors (PRGFs) eye drops preserve
their activity and biological properties after storage for 9 and 12 months at− 20 C, and at 4 C …

Therapeutic proteins for treatment of corneal epithelial defects

EY Zernii, VE Baksheeva, EV Yani… - Current Medicinal …, 2019 - ingentaconnect.com
Corneal epithelial disorders take pride of place in modern ophthalmology. Defects of corneal
epithelium are commonly accompanied by blurry vision, photophobia and tearing. Since …

The effect of plasma rich in growth factors on microglial migration, macroglial gliosis and proliferation, and neuronal survival

N Ruzafa, X Pereiro, A Fonollosa, J Araiz… - Frontiers in …, 2021 - frontiersin.org
Plasma rich in growth factors (PRGF) is a subtype of platelet-rich plasma that has being
employed in the clinic due to its capacity to accelerate tissue regeneration. Autologous …

Oral pemphigoid recalcitrant lesion treated with PRGF infiltration. Case report

E Anitua, MH Alkhraisat, A Eguia, L Piñas - Dentistry Journal, 2021 - mdpi.com
Mucous membrane pemphigoid (MMP) is a heterogeneous group of chronic autoimmune
subepithelial blistering diseases. Oral involvement is present in almost all patients, may …

Anti-inflammatory effect of different PRGF formulations on cutaneous surface

E Anitua, A Pino, L Aspe, MI Martinez, A García… - Journal of Tissue …, 2021 - Elsevier
Cutaneous autoimmune and inflammatory diseases are a major burden of global disease
and many lack effective treatments that can derive in different dermatoses like atopic …

Dry Eye Syndrome Preferred Practice Pattern®

G Amescua, S Ahmad, AY Cheung… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Dry Eye Syndrome Preferred Practice Pattern® Dry Eye Syndrome Preferred Practice Pattern®
Ophthalmology. 2024 Apr;131(4):P1-P49. doi: 10.1016/j.ophtha.2023.12.041. Epub 2024 Feb …

Initial experiences using plasma rich in growth factors to treat keratoneuralgia

M Wang, S Yennam, S Pflugfelder - Frontiers in medicine, 2022 - frontiersin.org
Keratoneuralgia, a clinical diagnosis of sensitized corneal pain without visible ocular surface
damage, generally has minimal response to conventional therapies. Causes include …